Business Context and Reporting Period
This Form 8-K was filed by BioZone Pharmaceuticals, Inc. (not Cocrystal Pharma, Inc.) on September 10, 2013. The report details the consummation of a settlement agreement regarding competing claims with former Executive Vice President Daniel Fisher.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or debt levels. The only specific financial figure disclosed is a one-time settlement payment of $1,050,000 made to Mr. Fisher.
Material Changes and Events
- Settlement Payment: The Company paid $1,050,000 to resolve claims filed by Mr. Fisher in the U.S. District Court for the Northern District of California and claims filed by the Company against Mr. Fisher in the Supreme Court of New York.
- Share Transfer: As a condition of the settlement, Mr. Fisher sold his entire holding of 6,650,000 shares of Company common stock to various private accredited investors on September 10, 2013.
- Legal Releases: The agreement includes mutual releases of all claims, including those related to the sale of BioZone Laboratories, Inc. (BZL), compensation disputes, and lease obligations owed to Mr. Fisher's entity, 580 Garcia Properties, LLC.
- Administrative Actions: Mr. Fisher agreed to seek dismissal of all administrative claims and investigations he had initiated against the Company with state or federal agencies.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future operations. The primary risk addressed is the resolution of litigation; the agreement stipulates that no party admitted to wrongdoing and that all parties agreed not to disparage one another. Mr. Fisher remains bound by non-competition terms from his former employment agreement.
Investor Verification Checklist
- Verify the impact of the $1,050,000 cash outflow on the Company's current liquidity position.
- Confirm the identity of the private accredited investors who acquired the 6,650,000 shares previously held by Mr. Fisher.
- Review the Company's most recent 10-K or 10-Q to assess the status of the lease obligations with 580 Garcia Properties, LLC that were released in this settlement.
- Ensure that all administrative claims mentioned in the settlement have been formally dismissed by the relevant agencies.